{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:55:20Z","timestamp":1781844920773,"version":"3.54.5"},"reference-count":29,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Introduction: Glycemic control in patients with type 2 diabetes mellitus undergoing intermittent hemodialysis represents a clinical challenge. The pathophysiological alterations inherent to chronic kidney disease (CKD) and the dialysis procedure limit the usefulness of traditional metrics. In this context, continuous glucose monitoring (CGM) enables dynamic assessment of glycemic profiles and can reveal patterns of dysglycemia that go undetected in routine clinical practice. Methods: An observational, cross-sectional, and analytical pilot study involved 10 patients from the hemodialysis (HD) unit. CGM was carried out for 14 days. A paired analysis was performed to compare glycemic parameters on days with and without HD. Statistical evaluation was performed using the Shapiro\u2013Wilk test and Student\u2019s t-test; a p-value &lt; 0.05 indicated statistical significance. Results: Time in range (TIR) showed considerable interindividual variability (24\u2013100%), with hyperglycemia being the predominant factor. During HD sessions, glucose levels showed a marked intradialytic decline followed by incomplete post-dialysis recovery, a pattern that differed from non-dialysis days (paired t-test, p &lt; 0.001; n = 10 paired observations). These findings should be interpreted as exploratory. Hypoglycemic episodes were infrequent, whereas persistent hyperglycemia prevailed. Conclusions: CGM reveals metabolic dysregulation frequently overlooked by traditional indicators such as glycated hemoglobin (HbA1c). These exploratory findings suggest that CGM may provide clinically relevant information in this population, although larger studies are needed before therapeutic recommendations can be established.<\/jats:p>","DOI":"10.3390\/medsci14020324","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:46:28Z","timestamp":1781588788000},"page":"324","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycemic Patterns Revealed by Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Intermittent Hemodialysis: A Pilot Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-0147","authenticated-orcid":false,"given":"Miguel Angel","family":"Cuevas-Budhart","sequence":"first","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Nefrol\u00f3gicas del Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel Salvador","family":"Becerra-Barrera","sequence":"additional","affiliation":[{"name":"Nephrology Department, Unidad M\u00e9dica de Alta Especialidad del Hospital de Especialidades Bernardo Sep\u00falveda Guti\u00e9rrez, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio Iv\u00e1n","family":"Silva-Rueda","sequence":"additional","affiliation":[{"name":"Nephrology Department, Unidad M\u00e9dica de Alta Especialidad del Hospital de Especialidades Bernardo Sep\u00falveda Guti\u00e9rrez, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vallejo-Avalos","sequence":"additional","affiliation":[{"name":"Facultad de Estudios Superiores Iztacala, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Tlalnepantla de Baz 54090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricruz","family":"Ponce-Villavicencio","sequence":"additional","affiliation":[{"name":"Nephrology Department, Unidad M\u00e9dica de Alta Especialidad del Hospital de Especialidades Bernardo Sep\u00falveda Guti\u00e9rrez, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bego\u00f1a","family":"Ilabaca Avenda\u00f1o","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital General de Zona No. 2A Venados, Instituto Mexicano del Seguro Social, Mexico City 15850, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-9682","authenticated-orcid":false,"given":"Marcela","family":"\u00c1vila-D\u00edaz","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Nefrol\u00f3gicas del Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-9707","authenticated-orcid":false,"given":"Ram\u00f3n","family":"Paniagua","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Nefrol\u00f3gicas del Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.12.001","article-title":"US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"81","author":"Johansen","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lee, S., Lee, S., Kim, K.M., and Shin, J.H. (2023). Usefulness of continuous glucose monitoring of blood glucose control in patients with diabetes undergoing hemodialysis: A pilot study. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1145470"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chan, C.P., Jagadesh, G., Bellary, S., and Baharani, J. (2026). Continuous glucose monitoring (CGM) use in people living with diabetes on maintenance dialysis: A retrospective audit and observational cohort study. BMC Nephrol., 27.","DOI":"10.1186\/s12882-026-04816-1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/sdi.12198","article-title":"Updates on the management of diabetes in dialysis patients","volume":"27","author":"Rhee","year":"2014","journal-title":"Semin. Dial."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ling, J., Ng, J.K.C., Chan, J.C.N., and Chow, E. (2022). Use of Continuous Glucose Monitoring in the Assessment and Management of Patients with Diabetes and Chronic Kidney Disease. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.869899"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","article-title":"Glycemic Monitoring and Management in Advanced Chronic Kidney Disease","volume":"41","author":"Galindo","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneph.2015.38","article-title":"Hemodialysis-induced hypoglycaemia and glycaemic disarrays","volume":"11","author":"Abe","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zaitoon, H., Abdul-Ghani, M., and DeFronzo, R.A. (2026). Insulin resistance and hyperinsulinaemia in kidney disease: Mechanisms and metabolic effects. Nat. Rev. Nephrol.","DOI":"10.1038\/s41581-026-01066-0"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/dc06-2127","article-title":"A1C and survival in maintenance hemodialysis patients","volume":"30","author":"Kopple","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/hdi.13073","article-title":"Glucose variability in maintenance hemodialysis patients with type 2 diabetes: Comparison of dialysis and nondialysis days","volume":"27","author":"Bomholt","year":"2023","journal-title":"Hemodial. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40620-023-01802-w","article-title":"Continuous glucose monitoring in people with diabetes and end-stage kidney disease\u2014Review of association studies and Evidence-Based discussion","volume":"37","author":"Jakubowska","year":"2024","journal-title":"J. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MNH.0000000000001106","article-title":"Continuous glucose monitoring and automated insulin delivery systems in the management of diabetes among individuals with chronic kidney disease on dialysis","volume":"34","author":"Liarakos","year":"2025","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hayashi, A., Takaesu, R., Sogabe, H., Tani, Y., Aoki, N., Ko, Y., Tsuji, S., Moriguchi, I., Kobayashi, N., and Miyatsuka, T. (2026). Continuous glucose monitoring reveals distinct clinical implications of glucose levels at the start and end of hemodialysis in people with type 2 diabetes. BMC Endocr. Disord., 26.","DOI":"10.1186\/s12902-026-02261-7"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2337\/dc24-0635","article-title":"Accuracy of Continuous Glucose Monitoring in Hemodialysis Patients with Diabetes","volume":"47","author":"Narasaki","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.34067\/KID.0000000000000396","article-title":"Continuous Glucose Monitoring and Reduced Diabetes-Related Hospitalizations in Patients with Type 2 Diabetes and CKD","volume":"5","author":"Hannah","year":"2024","journal-title":"Kidney360"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cuevas-Budhart, M.A., Juncos R\u00edos, D.A., Ponce Villavicencio, M., Diaz, M.\u00c1., Avenda\u00f1o, M.B.I., Rocha-Carrillo, M.B., and Paniagua, R. (2025). Patient Experience with Continuous Glucose Monitoring During Dialysis in Type 2 Diabetes: A Qualitative Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14196943"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"(2024). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/cen.70036","article-title":"Association Between Serum Uric Acid to Creatinine Ratio and Time in Range in Patients with Type 2 Diabetes","volume":"103","author":"Gong","year":"2025","journal-title":"Clin. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The Relationship of Hemoglobin A1c to Time-in-Range in Patients with Diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"(2022). Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int., 102, S1\u2013S127.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dia.2010.0052","article-title":"Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis","volume":"12","author":"Mirani","year":"2010","journal-title":"Diabetes Technol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of Oxidative Stress by Acute Glucose Fluctuations Compared with Sustained Chronic Hyperglycemia in Patients with Type 2 Diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/19322968231173447","article-title":"Accuracy of Continuous Glucose Monitoring in an Insulin-Treated Population Requiring Hemodialysis","volume":"17","author":"Horne","year":"2023","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_25","first-page":"116","article-title":"Enfermedad renal cr\u00f3nica","volume":"55","year":"2018","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ekir.2022.03.029","article-title":"Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes","volume":"7","author":"Ling","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.7150\/ijms.102727","article-title":"Research Progress on the Application of CGM in Patients with Diabetes and Hemodialysis","volume":"21","author":"Huang","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hassanein, M., and Shafi, T. (2022). Assessment of glycemia in chronic kidney disease. BMC Med., 20.","DOI":"10.1186\/s12916-022-02316-1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15605\/jafes.035.01.12","article-title":"Glycemic Patterns and Factors Associated with Post-Hemodialysis Hyperglycemia among End-Stage Kidney Disease Patients undergoing Maintenance Hemodialysis","volume":"35","author":"Hanif","year":"2020","journal-title":"J. ASEAN Fed. Endocr. Soc."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:41:03Z","timestamp":1781844063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medsci14020324"],"URL":"https:\/\/doi.org\/10.3390\/medsci14020324","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}